Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1993
03/09/1993CA1314217C Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
03/09/1993CA1314214C Antineoplastic agent-entrapping liposomes
03/09/1993CA1314213C Phospholipid delivery vehicle for aqueous-insoluble active ingredients
03/09/1993CA1314211C Agent for reducing nephrotoxicity caused by cyclosporin administration
03/07/1993CA2077577A1 Condensed 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical preparations containing these compounds
03/07/1993CA2077465A1 Heterocyclically substituted quinolylmethoxy-phenylacetamides
03/07/1993CA2077283A1 Inhibitors of hiv reverse transcriptase
03/07/1993CA2077122A1 Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same
03/06/1993WO1993005052A1 Methanediphosphonic acid derivative, production thereof and medicinal use thereof
03/06/1993WO1993004679A1 Macrocyclic immunomodulators
03/06/1993CA2103453A1 Macrocyclic immunomodulators
03/06/1993CA2076722A1 Pharmaceutical agents
03/05/1993CA2077466A1 Substituted nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them
03/05/1993CA2077412A1 1,2-dihydro-2-oxopyridines
03/05/1993CA2077131A1 13beta-o-methoxymethyl-22,23-dihydro avermectin b1a-b1b aglycone as a superior antiparasitic agent
03/04/1993WO1993004373A1 Calcium receptor active molecules
03/04/1993WO1993004167A1 In vivo gene transfer using implanted retroviral producer cells
03/04/1993WO1993004073A1 Phosphorus-substituted isoprenoid derivative
03/04/1993WO1993004068A1 Cns active tetrahydrobenzothienopyridines
03/04/1993WO1993004067A1 Hypoglycemic n-sulfonyl-tetrahydro-[1,3]-dioxepino[5,6-b]azirines
03/04/1993WO1993004065A1 NEW 3-(SUBSTITUTED TETRAZOLYL)-4-OXO-4H-PYRIDO-[1,2-a]PYRIMIDINES, SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME
03/04/1993WO1993004064A1 Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents
03/04/1993WO1993004061A1 Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents
03/04/1993WO1993004060A1 Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents
03/04/1993WO1993004056A1 New leukotriene-b4 antagonists, methods of preparing them and their use as drugs
03/04/1993WO1993004055A2 Compounds used for the inhibition of hiv-protease
03/04/1993WO1993004052A1 Amide tetrazole acat inhibitors
03/04/1993WO1993004048A1 New pyrazine derivatives, their preparation and their use
03/04/1993WO1993004046A1 Angiotensin ii receptor blocking imidazolinone derivatives
03/04/1993WO1993004045A1 Angiotensin ii receptor blocking imidazolinone derivatives
03/04/1993WO1993004043A1 Anti-hiv (aids) agents
03/04/1993WO1993004041A1 Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
03/04/1993WO1993004040A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
03/04/1993WO1993004036A1 Synthetic aryl polyamines as excitatory amino acid neurotransmitter antagonists
03/04/1993WO1993004035A1 New 3,5-di-tert.butyl-4-hydroxyphenyl derivatives, methods of preparing them and drugs containing them
03/04/1993WO1993003770A1 Method and compositions for cellular reprogramming
03/04/1993WO1993003769A1 Adenovirus mediated transfer of genes to the gastrointestinal tract
03/04/1993WO1993003768A1 Isolation, growth, differentiation and genetic engineering of human muscle cells
03/04/1993WO1993003738A1 Method for treating vascular obstructions caused by abnormal cells
03/04/1993WO1993003736A1 Cross-linking oligonucleotides for enzyme-mediated triple strand formation
03/04/1993WO1993003734A1 Method for lowering blood lipid levels
03/04/1993WO1993003732A1 Gaba receptor modulators
03/04/1993WO1993003731A1 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
03/04/1993WO1993003730A1 Protein kinase c inhibition and novel compound balanol
03/04/1993WO1993003729A1 N-substituted phenoxazines for treating multidrug resistant cancer cells
03/04/1993WO1993003728A1 Xanthine suppression of antigen activation of t- or b-cells
03/04/1993WO1993003727A1 Use of certain xanthine derivatives and their pharmaceutically acceptable salts for the manufacture of a medicament useful for counteracting hypoclycaemia
03/04/1993WO1993003726A1 Muscarinic agonists
03/04/1993WO1993003725A1 5-ht4 receptor antagonists
03/04/1993WO1993003724A1 Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
03/04/1993WO1993003723A1 Leukotriene receptor antagonist-antihistamine complex
03/04/1993WO1993003722A1 Imidazolyl-alkenoic acids
03/04/1993WO1993003721A1 Cholecystokinin antagonists useful for treating depression
03/04/1993WO1993003720A2 Methods and compositions for treating sunburns
03/04/1993WO1993003718A1 Pharmaceutical composition containing carbachol and other cholinergic substances
03/04/1993WO1993003717A1 Cholecystokinin antagonists useful for treating depression
03/04/1993WO1993003716A1 Method of increasing intracellular accumulation of hydrophilic anionic agents using gemfibrizol
03/04/1993WO1993003715A1 Inhibitor for blood vessel hypertrophy
03/04/1993WO1993003713A1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
03/04/1993WO1993003709A1 Composition and method for treating cystic fibrosis
03/04/1993WO1993003697A1 Transdermal formulations for administering prazosin
03/04/1993WO1993003694A1 Transdermal administration of short or intermediate half-life benzodiazepines
03/04/1993WO1993003668A1 Cardiac output probe assembly
03/04/1993WO1993003649A1 Sustained-release martrices for dental application
03/04/1993WO1993000330A3 Azanorbornane derivatives
03/04/1993WO1993000313A3 Sigma receptor ligands and the use thereof
03/04/1993WO1993000094A3 Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
03/04/1993WO1992020650A3 Phosphite-borane compounds, and method of making and using the same
03/04/1993WO1992018123A3 A method for inhibition of retroviral replication
03/04/1993WO1992018089A3 Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells
03/04/1993DE4211883C1 Stable, heat-sterilisable carbamazepine soln. for parenteral admin. - comprises carbamazepine dissolved in tetra:hydro:furfuryl alcohol, polyethylene glycol ether, water and polyvinyl pyrrolidone
03/04/1993DE4135551A1 Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen Antagonists or partial agonists use of the 5-HT1A receptor for the treatment and prevention of cognitive impairment
03/04/1993DE4128690A1 Bicyclische sulfone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel Bicyclic sulfones, process for their production and containing the same drug
03/04/1993DE4128581A1 Thieno (3,2-f) (1,2,4)triazolo (4,3-a)(1,4) diazepine derivs. - useful for treatment and prevention of allergic rhinitis, in nasal spray, avoiding side effects
03/04/1993DE4128579A1 Use of thieno(3,2-f)(1,2,4) triazolo (4,3-a) (1,4) diazepine derivs. - for treatment and prevention of allergic rhinitis
03/04/1993CA2116118A1 Isolation, growth, differentiation and genetic engineering of human muscle cells
03/04/1993CA2116024A1 5-ht4 receptor antagonists
03/04/1993CA2115994A1 Protein kinase c inhibition and novel compound balanol
03/04/1993CA2115990A1 Angiotensin ii receptor blocking imidazolinone derivatives
03/04/1993CA2115989A1 Angiotensin ii receptor blocking imidazolinone derivatives
03/04/1993CA2115849A1 Phosphorus-containing isoprenoid derivatives
03/04/1993CA2115841A1 Transdermal administration of short or intermediate half-life benzodiazepines
03/04/1993CA2115840A1 Transdermal formulation for administering prazosin
03/04/1993CA2115755A1 New pyrazine derivatives, their preparation and their use
03/04/1993CA2115742A1 Adenovirus mediated transfer of genes to the gastrointestinal tract
03/04/1993CA2115675A1 Method for lowering blood lipid levels
03/04/1993CA2115581A1 Anti-hiv (aids) agents
03/04/1993CA2115364A1 Composition and method for treating cystic fibrosis
03/04/1993CA2115361A1 Method for treating vascular obstructions caused by abnormal cells
03/04/1993CA2115349A1 New 3,5-di-tert-butyl-4-hydroxyphenyl derivatives, processes for their preparation and medicaments
03/04/1993CA2115269A1 N-sulfonyl-tetrahydro-[1,3]-dioxepino[5,6-b]azirines, methods and intermediates for their preparation, and their use
03/04/1993CA2115262A1 In-vivo gene transfer using implanted retroviral producer cells
03/04/1993CA2114951A1 New leukotriene-b antagonists, methods of preparing them and their use as drugs
03/04/1993CA2114945A1 Leukotriene receptor antagonist-antihistamine complex
03/04/1993CA2114935A1 Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
03/04/1993CA2114798A1 Synthetic aryl polyamines as excitatory amino acid neurotransmitter antagonists
03/04/1993CA2114145A1 New 3-/substituted tetrazolyl/-4-oxo-4h-pyrido-/1,2-a/- pyrimidines, salts thereof, pharmaceutical compositions containing them and process for preparing same
03/04/1993CA2112397A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
03/04/1993CA2077314A1 Antisense oligonucleotides with phosphoramidate internucleotide linkage throughout
03/03/1993EP0530166A2 3-Hydroxy anthranilic acid derivatives for inhibiting 3-hydroxy anthranilate oxygenase
1 ... 7210 7211 7212 7213 7214 7215 7216 7217 7218 7219 7220 7221 7222 7223 7224 7225 7226 7227 7228 7229 7230 ... 7860